Abattis Bioceuticals (Abattis Bioceuticals) COGS-to-Revenue : 0.29 (As of Sep. 2019)

View and export this data going back to . Start your Free Trial

What is Abattis Bioceuticals COGS-to-Revenue?

Abattis Bioceuticals's Cost of Goods Sold for the three months ended in Sep. 2019 was $0.05 Mil. Its Revenue for the three months ended in Sep. 2019 was $0.17 Mil.

Abattis Bioceuticals's COGS to Revenue for the three months ended in Sep. 2019 was 0.29.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Abattis Bioceuticals's Gross Margin % for the three months ended in Sep. 2019 was 71.35%.

Abattis Bioceuticals COGS-to-Revenue Historical Data

The historical data trend for Abattis Bioceuticals's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abattis Bioceuticals COGS-to-Revenue Chart

Abattis Bioceuticals Annual Data

Trend

Sep10

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

COGS-to-Revenue

Get a 7-Day Free Trial

0.32

0.17

0.33

Abattis Bioceuticals Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	0.41	0.29

Abattis Bioceuticals COGS-to-Revenue Calculation

Abattis Bioceuticals's COGS to Revenue for the fiscal year that ended in Sep. 2019 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.088	/	0.27
	=	0.33

Abattis Bioceuticals's COGS to Revenue for the quarter that ended in Sep. 2019 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.049	/	0.171
	=	0.29

Abattis Bioceuticals (OTCPK:ATTBF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Abattis Bioceuticals's Gross Margin % for the three months ended in Sep. 2019 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.049 / 0.171
	=	71.35 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Abattis Bioceuticals COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Abattis Bioceuticals's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Abattis Bioceuticals (Abattis Bioceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abattis Bioceuticals Corp (OTCPK:ATTBF) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

1200 - 625 Howe Street, Vancouver, BC, CAN, V6C 2M6

Website

http://www.abattis.com

Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.